Biopharmaceutical research companies are conducting or have conducted more than 2,000 clinical trials of new medicines in the Piedmont Triad in collaboration with Wake Forest University School of Medicine, clinical research centers and hospitals (1999 to present). The Piedmont Triad consists of 12 North Carolina counties, including: Alamance, Caswell, Davidson, Davie, Forsyth, Guilford, Montgomery, Randolph, Rockingham, Stokes, Surry and Yadkin.
Of the more than 2,000 clinical trials, 902 have targeted the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
“The fact that we have top-notch university medical schools, hospitals and specialty treatment centers in the 12-county Piedmont Triad has made our region a center of clinical research. And that distinction should cause more than a few ripples of excitement, considering the resulting benefits to patients and the regional economy. Since 1999, institutions like Wake Forest University and Forsyth Medical Center in Winston-Salem, Alamance Regional Cancer Center in Burlington and Moses H. Cone Regional Cancer Center in Greensboro have conducted 2,007 clinical trials of potential new medicines. Over 900 of those trials have targeted our most devastating chronic diseases—heart disease, stroke, cancer, diabetes, mental illnesses and asthma.” --Dr. Johnny L. Williams, MD President, Old North State Medical Society